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ABSTRACT
Objective Data describing the prevalence,
characteristics and management of coronary chronic total
occlusions (CTOs) in patients undergoing coronary CT
angiography (CCTA) have not been reported. The
purpose of this study was to determine the prevalence,
characteristics and treatment strategies of CTO identiﬁed
by CCTA.
Methods We identiﬁed 23 745 patients who
underwent CCTA for suspected coronary artery disease
(CAD) from the prospective international CCTA registry.
Baseline clinical data were collected, and allocation to
early coronary revascularisation performed within
90 days of CCTA was determined. Multivariable
hierarchical mixed-effects logistic regression reporting OR
with 95% CI was performed.
Results The prevalence of CTO was 1.4% (342/
23 745) in all patients and 6.2% in patients with
obstructive CAD (≥50% stenosis). The presence of CTO
was independently associated with male sex (OR 3.12,
95% CI 2.39 to 4.08, p<0.001), smoking (OR 2.02,
95% CI 1.55 to 2.64, p<0.001), diabetes (OR 1.60,
95% CI 1.22 to 2.11, p=0.001), typical angina (OR
1.51, 95% CI 1.12 to 2.06, p=0.008), hypertension (OR
1.47, 95% CI 1.14 to 1.88, p=0.003), family history of
CAD (OR 1.30, 95% CI 1.01 to 1.67, p=0.04) and age
(OR 1.06, 95% CI 1.05 to 1.07, p<0.001). Most
patients with CTO (61%) were treated medically, while
39% underwent coronary revascularisation. In patients
with severe CAD (≥70% stenosis), CTO independently
predicted revascularisation by coronary artery bypass
grafting (OR 3.41, 95% CI 2.06 to 5.66, p<0.001), but
not by percutaneous coronary intervention (p=0.83).
Conclusions CTOs are not uncommon in a
contemporary CCTA population, and are associated with
age, gender, angina status and CAD risk factors. Most
individuals with CTO undergoing CCTA are managed
medically with higher rates of surgical revascularisation
in patients with versus without CTO.
Trial registration number ClinicalTrials.gov identiﬁer
NCT01443637.
INTRODUCTION
Coronary CT angiography (CCTA) is a useful non-
invasive tool that demonstrates high performance for
diagnosis and prognosis of coronary artery disease
(CAD).1–3 Further, CCTA demonstrates precision for
assessing the anatomical and morphological features
of occluded coronary arteries, and has been success-
fully employed in the planning of chronic total occlu-
sion (CTO) revascularisation.4–6
While the prevalence of CTO has been deﬁned for
individuals undergoing invasive coronary angiog-
raphy,7–10 data describing the prevalence and clinical
characteristics of occluded coronary arteries among
stable patients referred for non-invasive testing have
not been reported to date. To this end, whether CTO
inﬂuences the current management of CAD after
non-invasive imaging remains unclear. The purpose
of this investigation was to determine the prevalence
of CTO in a consecutive multinational CCTA popula-
tion and to provide detailed clinical and tomographic
characteristics associated with CTO. The inﬂuence of
CTO at the time of CCTA on treatment strategies
was additionally examined.
METHODS
Study population
The CONFIRM (COronary CT Angiography
EvaluatioN For Clinical Outcomes: An InteRnational
Multicenter) registry is an international multicentre
observational registry collecting clinical, procedural
and follow-up data of patients who underwent
CCTA between 2005 and 2010 at 17 centres in 7
countries (USA, Canada, Germany, Switzerland, Italy,
Austria and South Korea). A detailed description of
the study design has been published elsewhere.11 For
the purpose of the present analysis, patients who
underwent CCTA for suspected, but without prior
known CAD, were included. The exclusion criterion
of known CAD was deﬁned as previous myocardial
infarction and/or coronary revascularisation. Ethical
approval was obtained from each of the study
centres’ institutional review board committees, and
written informed consent was provided by the study
participants.
The CONFIRM registry employs a standardised
data collection method at all study sites to gather
information regarding baseline cardiovascular risk
factors, symptoms and medication before CCTA, as
well as detailed angiographic results and clinical
outcomes.12 Pretest probability of CAD was
deﬁned using the Diamond–Forrester score,13 and
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symptom presentation was classiﬁed into the following categor-
ies: typical chest pain, atypical chest pain and non-cardiac
pain.14 Coronary artery calcium was quantiﬁed according to the
method of Agatston. Details of this approach have been
described elsewhere.15
Image acquisition and analysis
CCTA data acquisition was performed using at minimum a
64-slice CT scanner with the imaging protocol adhering to the
Society of Cardiovascular Computed Tomography guidelines on
appropriateness and performance of CCTA.16 Dose-reduction
strategies, including ECG-gated tube current modulation,
reduced tube voltage and prospective axial triggering, were used
whenever possible, with estimated radiation doses for CCTA
ranging from 3 to 18 mSv.
Reconstructed data were evaluated in a uniform fashion
across all study sites by level III-qualiﬁed readers using all neces-
sary postprocessing techniques to determine the presence of
CAD. Coronary segments were scored visually for the presence
and composition of coronary plaque and degree of luminal sten-
osis with a 16-segment American Heart Association coronary
artery model.17 Plaque severity was graded on a per-segment,
per-vessel and per-patient level. Plaque composition in each cor-
onary segment was classiﬁed as non-calciﬁed, partially calciﬁed
or calciﬁed as deﬁned elsewhere.18 Coronary atherosclerotic
lesions were graded as normal (no atherosclerosis), mild (1%–
49% stenosis), moderate (50%–69% stenosis), severe (70%–
99%) or totally occluded (100%) in epicardial coronary arteries
of ≥2 mm in diameter. Coronary lesions with ≥50% luminal
stenosis severity were deﬁned as obstructive.
Per-vessel obstructive CAD was deﬁned by ≥50% stenosis
(including CTO) in 0, 1, 2 or 3 coronary artery vessels. For the
purpose of classiﬁcation for per-vessel analyses, we included
four arterial territories: left main artery, left anterior descending
artery, left circumﬂex artery and right coronary artery. The diag-
onal branches and obtuse marginal branches were considered as
part of the left anterior descending artery and left circumﬂex
artery system, respectively, whereas the posterolateral branches
and posterior descending artery were considered as part of the
right coronary artery or left circumﬂex artery system, depending
on the coronary artery dominance.19 Additionally, the proximal
segments were deﬁned as follows: left main, proximal and mid
left anterior descending artery; proximal left circumﬂex artery
and ﬁrst obtuse marginal branch; and proximal and mid right
coronary artery.18 Per-patient obstructive CAD was deﬁned by
the maximal stenosis in ≥1 coronary vessel at the 50% stenosis
threshold. Given that severe CAD (≥70% stenosis) is mainly
associated with coronary ischaemia, and the need for coronary
revascularisation, subanalyses were performed for patients with
at least one coronary stenosis at the ≥70% luminal narrowing
threshold to investigate CTO treatment allocation.
CTO was deﬁned as complete interruption of the
contrast-enhanced lumen of the coronary artery with recurrence
of luminal opaciﬁcation distal to the occlusion site as assessed by
multiplanar reconstructions by CCTA.20 21 The prevalence of
CTO was determined using two denominators: (1) all patients
undergoing CCTA and (2) patients with obstructive CAD.
Study outcomes
The primary endpoint was prevalent CTO as determined by
CCTA. In patients with follow-up for early coronary revasculari-
sation, a secondary endpoint of target vessel coronary revascu-
larisation performed within 90 days after the time of CCTA was
assessed.22
Statistical methods
Categorical variables were presented as counts with proportions
and were assessed using Pearson’s χ2 or Fisher’s exact test for
cell counts <6. Continuous variables were presented as mean
±SD when normally distributed or median with IQR when
non-normally distributed, and analysed using Student’s unpaired
t test or Mann–Whitney U test, as appropriate. The variables
with signiﬁcant missing values (>15%) were noted. Pairwise
comparisons of plaque morphology were obtained using one-
sample t tests, and were adjusted to account for multiple com-
parisons (ie, three pairwise comparisons) using the Bonferroni
method. Clinical variables known or suspected to be associated
with the presence of CTO or post-test revascularisation strat-
egies were assessed using univariable and multivariable hierarch-
ical mixed-effects logistic regression modelling, with hospital
sites considered random effects, reporting ORs with 95% CIs.
For this reason, we made the following assumptions: random
effects follow a Gaussian distribution, the conditional distribu-
tion of the response is assumed to be Bernoulli with probability
of success determined by cumulative distribution function, and
the log-likelihood is approximated by adaptive Gaussian quadra-
ture.23 Statistical signiﬁcance was accepted for two-tailed
p values <0.05. All calculations were performed using STATA
V.12.1 (Stata, College Station, Texas, USA).
RESULTS
Prevalence of CTO
Of a total of 27 125 screened adult patients, we excluded
patients with known CAD (n=2350), congenital heart disease
(n=111) and patients for whom clinical data regarding age,
gender or CAD severity were lacking (n=919), resulting in a
ﬁnal study sample of 23 745 individuals. The prevalence of
CTO for the entire study cohort (deﬁnition 1) was 1.4% (342/
23 745). In patients with obstructive CAD (≥50% stenosis
threshold), the prevalence of CTO was 6.2% (342/5559).
Clinical and angiographic characteristics of CTO
Demographic characteristics according to the presence or
absence of CTO by CCTA are reported in table 1. The majority
of individuals with CTO presented with a low-to-intermediate
probability of obstructive CAD. Approximately two-thirds of
the study sample presenting with CTO were symptomatic, with
the most common presentation of atypical angina, followed by
typical angina and non-cardiac chest pain. Mean age was higher
for patients with CTO, with a higher prevalence of male sex
and CAD risk factors with the exception of family history of
premature CAD. In patients with LVEF data availability (33% of
the study cohort), the majority of individuals with CTO exhib-
ited normal LVEF, although LVEF was signiﬁcantly lower among
patients with CTO.
Prevalence of signiﬁcant CAD among patients with CTO was
equally distributed into one-vessel (33%), two-vessel (31.9%)
and three-vessel or left-main CAD (35.1%). In total, 380 vessels
(172 right coronary arteries, 114 left anterior descending arter-
ies, 94 left circumﬂex arteries) were totally occluded, with the
majority of individuals with single-vessel CTO (89.2%), fol-
lowed by patients with two-vessel CTO (10.5%) and three-
vessel CTO (0.3%), respectively. The most common CTO was
the right coronary artery identiﬁed in 50.3% of patients with
CTO, with 33.3% and 27.4% of individuals manifesting left
anterior descending and left circumﬂex artery CTO, respectively.
The location of CTO was in the proximal portion of the coron-
ary arteries in the majority (57.1%) of cases (distribution of
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proximal occlusion per vessel: right coronary artery 63%; left
anterior descending artery 54.9%; left circumﬂex artery
45.5%), with most CTOs being calciﬁed or partially calciﬁed
(table 2).
Predictors of CTO
Multivariable mixed-effects logistic regression analyses revealed
CTO to be associated with male sex, current smoking status,
diabetes, typical angina, hypertension, family history of prema-
ture CAD and age. Conversely, the odds of prevalent CTO were
reduced on the background of normal LVEF (table 3).
Early treatment strategies
Follow-up for early coronary revascularisation was available in
15 163 of the study sample, of which CTO was prevalent in
281 (1.9%) patients. Most patients with CTO (61%) were
treated by medical therapy, while approximately one-third
(39%) underwent early coronary revascularisation by surgical or
percutaneous methods. In the subgroup of 1372 patients pre-
senting with at least one severe coronary stenosis (≥70%), those
with CTO were referred more often to coronary artery bypass
grafting in lieu of lower rates of percutaneous coronary inter-
vention as compared with patients without CTO (ﬁgure 1).
Table 1 Baseline characteristics of the study population
(n=23 745)
Chronic total occlusion
p Value
No
(n=23 403)
Yes
(n=342)
Age, years 57.2±12.6 64.7±10.8 <0.0001
Male 12 671 (54.1) 255 (74.6) <0.001
Hypertension 11 385 (49.1) 227 (67.2) <0.001
Hyperlipidaemia 12 566 (54.1) 226 (66.9) <0.001
Diabetes 3359 (14.4) 80 (23.7) <0.001
Family history of premature CAD 8476 (36.8) 124 (36.9) 0.96
Current smoker 4144 (17.8) 94 (27.8) <0.001
BMI, kg/m2* 27.3±5.2 27.7±4.6 0.04
LVEF, %† 61.8±11.4 57.2±15.4 0.0009
Normal LVEF, >50% 6551 (85.3) 124 (70.5) <0.001
Moderate LVEF, >30% ≤50% 968 (12.6) 38 (21.6) <0.001
Low LVEF, ≤30% 161 (2.1) 14 (8.0) <0.001
Pretest probability of obstructive CAD 34.6±29.1 41.9±33.5 <0.0001
Low 8970 (43.7) 141 (42.6) 0.68
Intermediate 9520 (46.4) 121 (36.6) <0.001
High 2021 (9.9) 69 (20.9) <0.001
Chest pain
Asymptomatic 6886 (33.6) 135 (40.8) 0.006
Non-cardiac 2333 (11.4) 38 (11.5) 0.95
Atypical angina 8235 (40.2) 84 (25.4) <0.001
Typical angina 3057 (14.9) 74 (22.4) <0.001
CCTA results (no. of vessels with ≥50% stenosis, including CTO)
Normal 10 097 (43.1) 0 <0.001
Non-obstructive 8089 (34.6) 0 <0.001
One-vessel disease 2984 (12.8) 113 (33.0) <0.001
Two-vessel disease 1228 (5.3) 109 (31.9) <0.001
Three-vessel disease or left main 1005 (4.3) 120 (35.1) <0.001
Values are mean±SD or n (%).
*BMI available in 78% of the cohort.
†LVEF available in 33% of the cohort.
BMI, body mass index; CAD, coronary artery disease; CCTA, coronary CT angiography;
CTO, chronic total occlusion; LVEF, left ventricular ejection fraction.
Table 2 Location and plaque morphology of chronic total
occlusion
No. of
occluded
segments
(%)
Plaque composition (%)
Calcified
Partially
calcified Non-calcified
Left main 0
LAD
Proximal 29 (8.5) 25.2±30.8 54.8±33.0* 20.0±24.3†
Medial 50 (14.6) 29.3±36.8 47.7±35.5* 22.9±30.8†
Distal 26 (7.6) 13.4±19.5‡ 49.5±28.5* 37.1±31.8
Diagonal artery 1 29 (8.5) 32.5±38.5 49.6±37.6 17.9±26.4†
Diagonal artery 2 10 (2.9) 21.7±24.3 54.2±29.9* 24.1±38.2
LCX
Proximal 17 (5.0) 13.5±18.4 55.4±33.7* 31.1±35.3
Distal 47 (13.7) 26.9±28.5 52.6±33.8* 20.5±28.6†
Obtuse marginal 1 33 (9.7) 24.5±32.5 56.3±33.2* 19.2±25.0†
Obtuse marginal 2 13 (3.8) 17.5±16.9 62.2±25.5* 20.3±21.7†
Left posterolateral
artery
0
RCA
Proximal 61 (17.8) 24.1±26.8 52.6±29.5* 23.3±27.2†
Medial 111 (32.5) 26.3±28.9 54.0±30.6* 19.7±25.7†
Distal 63 (18.4) 23.0±27.2 58.8±32.1* 18.1±25.4†
Right posterolateral
artery
13 (3.8) 44.9±35.7‡ 46.2±35.8 8.9±20.0†
Posterior descending
artery
25 (7.3) 41.2±38.3‡ 46.6±40.1 12.2±26.0†
Values are mean±SD or n (%).
*Significant differences between CP versus PCP.
†Significant differences between PCP versus NCP.
‡Significant differences between CP versus NCP.
CP, calcified plaque; LAD, left anterior descending artery; LCX, left circumflex artery;
NCP, non-calcified plaque; PCP, partially calcified plaque; RCA, right coronary artery.
Table 3 Univariable and multivariable mixed-effects regression
analyses for prediction of chronic total occlusion (n=23 745)
Univariable Multivariable
OR 95% CI p Value OR 95% CI p Value
Age, years 1.05 1.04 to 1.06 <0.001 1.06 1.05 to 1.07 <0.001
Male 2.46 1.92 to 3.14 <0.001 3.12 2.39 to 4.08 <0.001
Hypertension 1.96 1.56 to 2.47 <0.001 1.47 1.14 to 1.88 0.003
Hyperlipidaemia 1.70 1.35 to 2.14 <0.001 1.20 0.94 to 1.53 0.14
Diabetes 2.10 1.63 to 2.72 <0.001 1.60 1.22 to 2.11 0.001
Family history of
premature CAD
1.05 0.83 to 1.33 0.66 1.30 1.01 to 1.67 0.04
Current smoker 1.77 1.38 to 2.26 <0.001 2.02 1.55 to 2.64 <0.001
BMI, kg/m2 1.01 0.99 to 1.03 0.25 1.01 0.98 to 1.03 0.58
Chest pain
Asymptomatic 1.00 1.00
Non-cardiac 0.77 0.52 to 1.12 0.17 0.93 0.63 to 1.39 0.73
Atypical angina 0.67 0.50 to 0.88 0.005 0.82 0.61 to 1.10 0.19
Typical angina 1.45 1.09 to 1.95 0.01 1.51 1.12 to 2.06 0.008
Pretest probability
of obstructive CAD
per 10%
1.10 1.06 to 1.13 <0.001 1.15 0.91 to 1.46 0.24
LVEF (%)* 0.96 0.95 to 0.97 <0.001 0.96 0.95 to 0.98 <0.001
*LVEF was used as a continuous variable.
BMI, body mass index; CAD, coronary artery disease; LVEF, left ventricular ejection
fraction.
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Early referral patterns stratiﬁed by the presence of coronary
vessel disease showed that surgical revascularisation was most
often attempted in the subgroup of patients with CTO with
three-vessel or left-main CAD, whereas percutaneous coronary
revascularisation was most often chosen in subjects without
CTO, but with one-vessel disease (table 4). By multivariable
mixed-effects logistic regression analysis, early revascularisation
by percutaneous coronary intervention among patients with ≥1
severe coronary stenosis (≥70%) was related to typical angina
(OR 1.94, 95% CI 1.36 to 2.76, p<0.001), atypical angina (OR
1.66, 95% CI 1.21 to 2.29, p=0.002), age (OR 0.98, 95% CI
0.97 to 0.99, p=0.001) and hypertension (OR 0.76, 95% CI
0.58 to 1.00, p=0.048), and was not associated with the pres-
ence of CTO (OR 0.96, 95% CI 0.68 to 1.35, p=0.83).
Conversely, the presence of CTO (OR 3.41, 95% CI 2.06 to
5.66, p<0.001) was the strongest independent predictor for
early revascularisation by coronary artery bypass grafting among
patients with ≥1 severe coronary stenosis (≥70%), followed by
multivessel or left main obstructive CAD (OR 3.09, 95% CI
1.87 to 5.12, p<0.001), atypical angina (OR 1.71, 95% CI
1.01 to 2.92, p=0.047), current smoking status (OR 1.69, 95%
CI 1.06 to 2.68, p=0.027) and hyperlipidaemia (OR 1.68, 95%
CI 1.03 to 2.74, p=0.036). Patients with CTO referred to per-
cutaneous coronary intervention (n=68) versus coronary artery
bypass grafting (n=42) differed for the extent of obstructive
CAD, LV systolic function and hyperlipidaemia (table 5).
DISCUSSION
In a prospective contemporary multinational registry of consecu-
tive individuals undergoing CCTA, this present study set out to
determine the prevalence, characteristics and clinical manage-
ment of CTO among patients without prior known CAD. We
observed the prevalence of CTO to be low, but signiﬁcantly
increased in the presence of obstructive CAD. Presence of CTO
by CCTA was associated with male sex, current smoking, dia-
betes, hypertension, family history of CAD, age and angina
presentation. The majority of patients with CTO were symp-
tomatic and yet demonstrated well-preserved LV systolic func-
tion, with referral to coronary revascularisation in
approximately one-third of patients. Notably, the ﬁndings from
this study may be considered widely generalisable given the high
number of enrolled subjects and inclusion of multiple clinical
sites in North America, Europe and Asia.
To date, the prevalence of CTO has been assessed only in
higher risk patients undergoing invasive coronary angiog-
raphy.7–10 Prior studies have demonstrated frequencies of CTO
ranging from 35% to 52% among patients with obstructive
CAD.7 9 More recently, in a prospective three-centre coronary
angiography registry,10 CTOs were discovered in 18.4% of
patients with obstructive CAD. The disparity in the frequency
of CTO between the current ﬁndings and prior angiographic
reports is unsurprising given the generally lower risk presenta-
tion of CCTA population. Interestingly, the majority of indivi-
duals with CTO in our cohort presented with a
low-to-intermediate rather than high probability of obstructive
CAD. This study offers information incremental to that of
Figure 1 Early referral patterns
(within 90 days after CT angiography)
of patients with severe CAD (≥70%)
with and without CTO (n=1372).
Values are n (%). *p=0.02. †p<0.001.
CABG, coronary artery bypass grafting;
CAD, coronary artery disease; CCTA,
coronary CT angiography; CTO, chronic
total occlusion; NS, non-signiﬁcant;
PCI, percutaneous coronary
intervention.
Table 4 Early referral patterns of patients with severe CAD
(≥70%) with and without CTO stratified by the presence of
coronary vessel disease on CCTA (n=1372)
Chronic total occlusion
No (n=1091) Yes (n=281) p Value
Early medical therapy
One-vessel disease 323 (64.0) 68 (78.2) 0.01
Two-vessel disease 207 (62.4) 56 (62.2) 0.98
Three-vessel disease or left main 136 (53.5) 47 (45.2) 0.15
Early PCI
One-vessel disease 167 (33.1) 18 (20.7) 0.02
Two-vessel disease 101 (30.4) 24 (26.7) 0.49
Three-vessel disease or left main 73 (28.7) 26 (25.0) 0.47
Early CABG
One-vessel disease 15 (3.0) 1 (1.2) 0.49
Two-vessel disease 24 (7.2) 10 (11.1) 0.23
Three-vessel disease or left main 45 (17.7) 31 (29.8) 0.01
CABG, coronary artery bypass grafting; CAD, coronary artery disease; CCTA, coronary
CT angiography; CTO, chronic total occlusion; PCI, percutaneous coronary
intervention.
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invasive angiographic observations on CTO occurrence, and
extends the understanding of CTO prevalence in patients with a
lower likelihood presentation undergoing non-invasive
angiography.
To date, few studies have assessed the angiographic character-
istics of CTO in an unselected patient population. From data
developed through the 1997–1999 National Heart, Lung and
Blood Institute Dynamic Registry, CTOs were observed to be
most prevalent in the right coronary artery and least common in
the left circumﬂex artery.24 Similar results were encountered in
the prospective study of Fefer et al10 who identiﬁed the right
coronary artery as the site of CTO in the majority of cases.
These ﬁndings are in accordance with our present data conﬁrm-
ing the highest prevalence of CTO within the right coronary
artery region. Interestingly, we observed an equal distribution of
one-vessel, two-vessel and three-vessel or left main obstructive
disease among patients with CTO. Further, the majority of CTO
lesions showed calciﬁed or partially calciﬁed plaque morpholo-
gies. Provided that the extent and severity of calciﬁcation
increase with occlusion duration,25 this observation may be
interpreted as indirect evidence for the predominance of older
CTO in our cohort. These ﬁndings may offer clues as to the
pathogenesis of CTO, and large-scale longitudinal studies asses-
sing plaque composition and other atherosclerotic plaque fea-
tures among individuals at risk of CTO development now
appear warranted.
In a single-centre registry of 8004 patients undergoing inva-
sive coronary angiography, Christofferson et al9 linked periph-
eral vascular disease, smoking and hypertension to the presence
of CTO. Other angiographic studies either found increasing age
or prior myocardial infarction to be positively associated with
CTO.24 26 In lieu of these ﬁndings, the current investigation
may be considered the ﬁrst to report on clinical predictors and
symptomatic status of unselected patients with CTO undergoing
CCTA. Interestingly, while expectedly advancing age, male sex,
current smoking, diabetes, hypertension, family history of pre-
mature CAD and typical angina conferred higher risk for CTO,
we noted a strong relationship between increasing LVEF and
attenuation of risk of CTO. The present ﬁndings are in line with
prior pioneer studies emphasising the increasing prevalence,
severity and extent of CAD in patients with a higher burden of
main cardiovascular risk factors.13 27 Yet, the present study ﬁnd-
ings examining individuals with lower pretest probability of
obstructive CAD observed a non-negligible rate of CTOs, and
emphasise the importance of integration of CAD risk factors
and symptom presentation to forecast the presence of CTO. To
this end, the present data underline the need to develop a future
predictive model for identifying the presence of CTO in lower
risk populations, including asymptomatic subjects.
There are scant data about the practicing trends regarding
referral patterns and management for a CTO population.
Mostly, patients undergoing coronary revascularisation for CTO
have stable or progressive angina with preserved LV function
and/or documented ischaemia.28 29 In the present study, merely
39.1% of subjects with CTO were referred for early coronary
revascularisation despite most CTO individuals presenting with
symptoms consistent with angina and normal LV function.
Whether these individuals will derive clinical beneﬁt from CTO
revascularisation remains to be determined. By relevance, the
presence of CTO was related to signiﬁcantly higher surgical
revascularisation rates and lower percutaneous revascularisation
rates when compared with individuals presenting with severe
CAD, but without CTO. Further, in the current study, CTO was
the strongest predictor for coronary artery bypass grafting, but
was unrelated to the use of percutaneous coronary intervention.
This ﬁnding contrasts with a prior registry analysis employing
invasive catheterisation in which CTO was the strongest pre-
dictor against percutaneous coronary intervention with no sig-
niﬁcant impact on the referral patterns for coronary artery
bypass grafting.9 Instead, the rates of coronary revascularisation
by either percutaneous coronary intervention or coronary artery
bypass grafting observed in the current study corresponded well
with ﬁndings of a more recent prospective angiography regis-
try.10 The disparity between our and prior angiographic studies
with regard to early management of patients with CTO may be
temporally inﬂuenced, or may represent a function of differing
pretest probability presentations as well as wide variability
between percutaneous coronary intervention centres in success-
ful revascularisation of CTO. Not surprisingly, patients referred
for coronary artery bypass grafting presented with more exten-
sive CAD, including left main involvement, and worse LV sys-
tolic function than patients referred for percutaneous coronary
intervention. This ﬁnding may, in part, explain the stronger
association between the presence of CTO and early revasculari-
sation by coronary artery bypass grafting than percutaneous cor-
onary intervention.
This study is not without limitations. This was an observa-
tional multicentre registry with variable pretest probability of
CAD for individuals at different sites. Yet, the results of this
study regarding the prevalence and signiﬁcance of CTO among
patients referred for CCTA were based on the largest currently
available pooled patient cohort, and may serve to generate
hypotheses for the design of future trials. The adopted deﬁn-
ition of CTO did not account for the estimated time of occlu-
sion prior to non-invasive angiographic interrogation, which
Table 5 Clinical presentation of patients with CTO referred to PCI
versus CABG for early coronary revascularisation (n=110)
Early PCI
(n=68)
Early CABG
(n=42) p Value
Age, years 63.8±10.9 65.2±8.7 0.55
Male 46 (67.7) 33 (78.6) 0.22
Hypertension 44 (65.7) 21 (51.2) 0.14
Hyperlipidaemia 42 (63.6) 35 (85.4) 0.02
Diabetes 15 (22.1) 10 (24.4) 0.78
Family history of premature CAD 24 (36.4) 14 (34.2) 0.82
Current smoker 20 (29.4) 10 (24.4) 0.57
BMI, kg/m2 27.7±3.9 27.6±3.9 0.69
LVEF, %* 59.4±12.1 52.2±14.1 0.03
Pretest probability of obstructive CAD 48.5±33.5 53.4±33.3 0.37
Low 21 (31.3) 10 (26.3) 0.59
Intermediate 29 (43.3) 16 (42.1) 0.91
High 17 (25.4) 12 (31.6) 0.49
Chest pain
Asymptomatic 18 (26.9) 10 (26.3) 0.95
Non-cardiac 7 (10.5) 5 (13.2) 0.75
Atypical angina 25 (37.3) 10 (26.3) 0.25
Typical angina 17 (25.4) 13 (34.2) 0.34
CCTA results (no. of vessels with ≥50% stenosis, including CTO)
One-vessel disease 18 (26.5) 1 (2.4) 0.001
Two-vessel disease 24 (35.3) 10 (23.8) 0.21
Three-vessel disease or left main 26 (38.2) 31 (73.8) <0.001
*LVEF available only in 42% of the CTO group.
BMI, body mass index; CABG, coronary artery bypass grafting; CAD, coronary artery
disease; CCTA, coronary CT angiography; CTO, chronic total occlusion; LVEF, left
ventricular ejection fraction; PCI, percutaneous coronary intervention.
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may have inﬂuenced the perceived rate of revascularisation of
occluded vessels in our cohort. Based on a previous histopath-
ology study,25 however, the predominance of calciﬁed and par-
tially calciﬁed CTO morphology are in accordance with
observations in the present study, and may offer clues as to the
approach of CTOs once identiﬁed by CCTA. CTO was deﬁned
by CCTA and not coronary angiography; therefore, the possibil-
ity of false-positive and false-negative CCTA ﬁndings may exist.
Finally, the reported referral patterns of patients with CTO to
percutaneous coronary intervention or coronary artery bypass
grafting were not governed by standard criteria, but rather clin-
ician discretion. Thus, the possibility of selection bias that is
present in all observational studies cannot be discounted.
CONCLUSIONS
The present study represents the ﬁrst data to determine the
prevalence, characteristics and treatment strategies of CTO
among patients undergoing non-invasive angiography for sus-
pected CAD in a contemporary clinical setting; and demon-
strates a low, but non-negligible, rate of CTO that is more
prevalent in individuals with obstructive CAD and low-to-
intermediate probability of obstructive CAD. The presence of
CCTA-identiﬁed CTO was strongly associated with age, gender,
angina status and CAD risk factors. Despite the presence of
symptoms and preserved LVEF, the majority of patients with
CTO were managed medically, with CTO a stronger predictor
of surgical rather than percutaneous revascularisation.
Key messages
What is already known on this subject?
While coronary CT angiography (CCTA) has been successfully
employed in the planning of chronic total occlusion (CTO)
revascularisation, data describing the prevalence, characteristics
and management of CTO in patients undergoing CCTA for
suspected coronary artery disease (CAD) have not been
reported.
What might this study add?
The present study demonstrates that: (1) CTO are not
uncommon in a contemporary CCTA population, and are more
prevalent in individuals with obstructive CAD; (2) the presence
of CTO is strongly associated with age, gender, angina status
and CAD risk factors and (3) despite the presence of symptoms,
the majority of patients with CCTA-identiﬁed CTO were
managed medically, with CTO being a stronger predictor of
surgical rather than percutaneous revascularisation.
How might this impact on clinical practice?
This study offers information incremental to developing a future
predictive model for identifying the presence of CTO in patients
undergoing non-invasive CCTA, and indicates the need for
deﬁning the most optimal treatment strategies of CTO in a
contemporary CCTA population.
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